Drugs / Pooled allogeneic fecal microbiotherapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05762211 | Oct 2023 → Oct 2026 expected | disease related to hematopoietic stem cell transplant | MaaT Pharma | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pooled allogeneic fecal microbiotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05762211 ↗ |
| Route | Oral | “Capsule for oral use” NCT05762211 ↗ |